Your browser doesn't support javascript.
loading
Crescentic glomerulonephritis in children: a single centre experience.
Özlü, Sare Gülfem; Çaltik, Aysun; Aydog, Özlem; Bülbül, Mehmet; Demircin, Gülay; Çakici, Evrim; Arda, Nilüfer; Öner, Ayse.
Affiliation
  • Özlü SG; Department of Pediatric Nephrology, Dr Sami Ulus Childrens and Maternity Hospital, Ankara, Turkey. saredr@gmail.com.
  • Çaltik A; Department of Pathology, Sami Ulus Childrens and Maternity Hospital, Ankara, Turkey. saredr@gmail.com.
  • Aydog Ö; Department of Pediatric Nephrology, Dr Sami Ulus Childrens and Maternity Hospital, Ankara, Turkey.
  • Bülbül M; Department of Pediatric Nephrology, Dr Sami Ulus Childrens and Maternity Hospital, Ankara, Turkey.
  • Demircin G; Department of Pediatric Nephrology, Dr Sami Ulus Childrens and Maternity Hospital, Ankara, Turkey.
  • Çakici E; Department of Pediatric Nephrology, Dr Sami Ulus Childrens and Maternity Hospital, Ankara, Turkey.
  • Arda N; Department of Pediatric Nephrology, Dr Sami Ulus Childrens and Maternity Hospital, Ankara, Turkey.
  • Öner A; Department of Pathology, Sami Ulus Childrens and Maternity Hospital, Ankara, Turkey.
World J Pediatr ; 12(2): 225-30, 2016 May.
Article in En | MEDLINE | ID: mdl-26684304
ABSTRACT

BACKGROUND:

Crescentic glomerulonephritis (CsGN) is characterized by crescents in 50% or more of glomeruli and clinically by a sudden and progressive decline in renal function.

METHODS:

We evaluated the etiology, clinical features, prognostic factors and long-term outcome of CsGN. Between January 2000 and December 2010, 45 children (26 girls, 19 boys) with biopsy-proven CsGN (>50% crescents) were investigated retrospectively.

RESULTS:

The mean age of the patients was 130.86±33.77 months. The mean duration of symptoms prior to diagnosis was 26±12 days (4-40 days). Most of the children had hypertension (62.2%), macroscopic hematuria (73.3%), oligoanuria (44.4%), edema (51.1%) and purpuric rash (40%) at presentation. The final clinical status of the patients was complete remission (n=21), partial remission (n=5) or chronic kidney disease (n=19). Adverse outcomes were significantly associated with a long duration between the onset of symptoms and treatment (P=0.038), the presence of oligoanuria (P=0.006), a severe decreased glomerular filtration rate (GFR <30 mL/min/1.73m²) and the need for dialysis (P=0.003) on admission, the ratio of crescents (>75%) (P=0.03), and the ratio of fibrous crescents (P=0.015).

CONCLUSION:

The outcome of CsGN in children continues to be poor, and it should be treated as a renal emergency.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Female / Humans / Male Language: En Journal: World J Pediatr Journal subject: PEDIATRIA Year: 2016 Document type: Article Affiliation country: Turquía

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Female / Humans / Male Language: En Journal: World J Pediatr Journal subject: PEDIATRIA Year: 2016 Document type: Article Affiliation country: Turquía